Mercer Global Advisors
MBX

Mercer Global Advisors’s MBX Biosciences MBX Stock Holding History

Mercer Global Advisors’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.5K Buy
+553
New +$19.3K ﹤0.01% 4597

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Mercer Global Advisors's MBX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in MBX Biosciences (MBX) in Q2 2026: 553 shares worth $30.5K. The stake represents ﹤0.01% of the portfolio and ranks #4597 among its holdings.

143 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Mercer Global Advisors held 553 shares of MBX Biosciences worth $30.5K as of Q2 2026.
  • MBX Biosciences was a new Mercer Global Advisors position in Q2 2026.
  • MBX Biosciences made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4597 holding.
  • 143 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.